AXQ Capital’s MacroGenics MGNX Stock Holding History

AXQ Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-78,850	Closed	-$228K	–	1202
2026 Q1	$228K	Buy	+78,850	New	+$168K	0.03%	693

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AXQ Capital's MGNX Position: Q2 2026 in Review

AXQ Capital sold out of MacroGenics (MGNX) in Q2 2026, closing a stake of 78,850 shares — an estimated $228K sold.

AXQ Capital first reported a position in MGNX in Q1 2026 and held it in 1 quarter. The position peaked at $228K in Q1 2026. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

AXQ Capital reported no remaining MacroGenics position as of Q2 2026 after selling out during the quarter.
AXQ Capital sold 78,850 MacroGenics shares in Q2 2026, an estimated $228K.
AXQ Capital first reported a position in MacroGenics in Q1 2026 and held it in 1 quarter.
AXQ Capital's MacroGenics position peaked at $228K in Q1 2026.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.